United States · FDA National Drug Code directory
pyrazinamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0812_05eb3847-557f-460c-951f-e614fb9f9045
- Product NDC
- 0054-0812
- Form
- TABLET
- Composition / generic term
- pyrazinamide
- Labeler
- Hikma Pharmaceuticals USA Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240830
- Source listing expiry
- 20261231
Source-listed ingredients
- PYRAZINAMIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 CONTAINER (0054-0812-21) · 0054-0812-21
- 90 TABLET in 1 CONTAINER (0054-0812-22) · 0054-0812-22
- 100 TABLET in 1 CONTAINER (0054-0812-25) · 0054-0812-25
- 500 TABLET in 1 CONTAINER (0054-0812-29) · 0054-0812-29
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →